Announcements, appointments and milestones from BIOVERIC Pharmaceuticals.
Back to homeBIOVERIC Pharmaceuticals marks its second anniversary with a redesigned website at bioveric.com, and a two-year record of six programs advanced into development and more than ten patent applications filed.
Our CEO, Sandip Patel, will pitch at the TiE New Jersey Nurture Cohort 3 Demo Day on June 5th.
BIOVERIC Pharmaceuticals will attend the CPHI Americas 2025 conference, connecting with partners across the global pharmaceutical supply chain.
Founder & CEO Sandip Patel will present at the 1st Pitch Life Science office hour hosted by Mid Atlantic Bio Angels.
BIOVERIC Pharmaceuticals has been selected for the Nurture Program Cohort 3 at TiE New Jersey — a mentorship program supporting high-potential ventures.
BIOVERIC Pharmaceuticals will attend BioLabs Investor Day on April 22, 2025 in Philadelphia.
Dr. Sripal Reddy Palavai, Ph.D., has joined the BIOVERIC Pharmaceuticals Advisory Board, bringing more than two decades of scientific and industry expertise.
Dr. Vijay Naringrekar joins the BIOVERIC Pharmaceuticals Advisory Board with over 30 years of industry experience in pharmaceutical development.
BIOVERIC Pharmaceuticals is licensing its first laboratory space at Princeton Innovation Center BioLabs in Princeton, New Jersey.
BIOVERIC Pharmaceuticals is pleased to announce the appointment of Mr. Sandip Patel as Chief Executive Officer.
